Cytokines and particularly IL-33, a ligand of IL1RAP, released by AML cause the remodeling of vasculature, reduces its ability to support normal hematopoiesis, and compromise vascular integrity by niche cell based stimulation of myeloid cytokine production. This evidence concerns the gene IL1RAP and acute myeloid leukemia.